Merck to Unveil Latest Findings at 2024 ASCO Annual Meeting Showcasing Progress in Innovative Oncology Treatments Across Extensive Portfolio and Varied Pipeline
Merck, also known as MSD outside the United States and Canada, is set to unveil a wealth of data at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, spanning various oncology medicines and pipeline candidates targeting over 25 types of cancer. These presentations highlight Merck’s ongoing commitment to advancing cancer research…